topotecan has been researched along with Leishmaniasis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Corbeil, A; d'Annessa, I; do Monte-Neto, RL; Fernandez-Prada, C; Leprohon, P; Rosa-Teijeiro, C; Wagner, V | 1 |
1 other study(ies) available for topotecan and Leishmaniasis
Article | Year |
---|---|
Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan.
Topics: Antineoplastic Agents; Antiprotozoal Agents; DNA Topoisomerases, Type I; Drug Repositioning; Drug Resistance; Leishmania infantum; Leishmaniasis; Molecular Dynamics Simulation; Mutation; Topoisomerase I Inhibitors; Topotecan; Whole Genome Sequencing | 2021 |